BBH

Tactical Allocation Channel

Race for Cure Drives Biotech Stocks

By VanEckMay 30, 2020

Tactical Allocation Channel

Biotech Benefits as Companies Race to Cure Coronavirus

By Tom LydonMay 26, 2020

Featured

What Are The Sectors for a “New Economy?”

By Dave NadigMay 22, 2020

Featured

AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs

By Ian YoungMay 21, 2020

Featured

Dave Nadig Talks Biotech ETFs to Watch On Yahoo Finance

By Aaron NeuwirthMay 18, 2020

Featured

Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead

By Ian YoungApril 23, 2020

Tactical Allocation Channel

Biotech ETFs Brush Off Political Attacks on Drug Prices

By Tom LydonJanuary 21, 2020

Tactical Allocation Channel

Expect More From Biotech ETFs in 2020

By Tom LydonDecember 20, 2019

Innovative ETFs Channel

Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene

By Max ChenNovember 1, 2019

Tactical Allocation Channel

Biotech ETFs Had A Rough Third Quarter

By Todd ShriberSeptember 30, 2019

Featured

8 High Flying Biotech ETFs for 2019

By Ian YoungMay 28, 2019

Tactical Allocation Channel

Biotech ETFs Could Use Some Mergers & Acquisitions

By Tom LydonMay 17, 2019

Equity ETFs

Biotech ETFs Climb on Biogen’s Promising Clinical Trial

By Max ChenJuly 6, 2018

Investing

Try This ETF Pair to Round Out Biotech Exposure

By David DierkingMarch 23, 2018

Equity ETFs

Biotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from Obamacare

By Max ChenJanuary 4, 2017

Equity ETFs

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

By Max ChenDecember 23, 2016

Equity ETFs

10 Best & Worst ETF Performers of the Day (May 11)

By Brenton GarenMay 11, 2016

Equity ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016